Prof. Dr. med. Mahfoud, Felix

Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes

Publications:

Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany

Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide

Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

Hidden sodium in effervescent-tablet dietary supplements and over-the- counter drugs: a comparative cross-sectional study

Declining rates of fixed-dose combination pills for hypertension in Germany from 2016 to 2023

Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study

“Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription

Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany